NCT06119425Completed
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice in the Outpatient Clinical Settings in the Appalachian Highlands
Source: ClinicalTrials.gov · Last updated 10 Feb 2026
Brief summary (registry, in English)
This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 231 (actual)
- First submitted
- 1 Nov 2023
- Start date
- 12 Oct 2023
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Ballad Health
- Diseases
- Colorectal cancer
- NCT number
- NCT06119425
What you commit to
- Study type: Interventional
- Participants enrolled: 231
- From 12 Oct 2023 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a previous abnormal colonoscopy finding who are due for surveillance.
Other illness
- Patients with a personal history of CRC
- Patients with a known high-risk family history of CRC precluding the patient from being average risk
- Patients with known diagnosis of inflammatory bowel disease or history of polyps
- Patients with any known medical condition which, in the opinion of the investigator, should preclude enrollment into the study
Other
- Patients who are currently symptomatic for CRC such as: blood in the stool
- Have a recorded up to date CRC screening
Who the study is looking for
- Patients aged 45-84 years of age (inclusive)
- Considered by health-care providers to be "average risk" for CRC as determined by USPSTF guidelines
- If a patient opts for blood-based test, they are able and willing to provide blood samples per protocol
- Ability to understand and the willingness to participate in the study
Age in the registry: 45 years to 84 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johnson City Medical Center Coordinator of this site? Confirm its status | Johnson City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.